AI Verdict
GOSS has stronger fundamentals based on our AI analysis.
GOVX vs GOSS Fundamental Comparison
| Metric | GOVX | GOSS |
|---|---|---|
| Revenue | $2.5M | $48.5M |
| Net Income | $-17.0M | $-170.4M |
| Net Margin | -684.8% | -351.5% |
| ROE | -347.4% | N/A |
| ROA | -253.2% | -98.9% |
| Current Ratio | 3.57x | 2.64x |
| Debt/Equity | 0.00x | N/A |
| EPS | N/A | $-0.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GOVX vs GOSS: Frequently Asked Questions
Is GOVX or GOSS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GOSS has stronger fundamentals. GOVX is rated STRONG SELL (86% confidence) while GOSS is rated STRONG SELL (90% confidence). This is not investment advice.
How does GOVX compare to GOSS fundamentally?
GeoVax Labs, Inc. has ROE of -347.4% vs Gossamer Bio, Inc.'s N/A. Net margins are -684.8% vs -351.5% respectively.
Which stock pays higher dividends, GOVX or GOSS?
GOVX has a dividend yield of N/A or no dividend while GOSS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GOVX or GOSS for long term?
For long-term investing, consider that GOVX has STRONG SELL rating with 86% confidence, while GOSS has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GOVX vs GOSS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GOVX vs GOSS, the AI consensus favors GOSS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.